| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.84 | 0.005 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.37 | 0.007 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.007 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |